Conferences

Reports

Media

Professional Services

Header Graphic

May 10, 2008

| CHI Conferences > White Papers

Add to Del.icio.us

Add to furl

Add to digg

Add to Connotea

EMail Page

Printer Friendly

Book Mark

Complimentary White Papers

Strategic Considerations for the U.S. Pharmaceutical Industry

A Collection of Interviews by Thomson CenterWatch

Breathing New Life into Structure-Based Design

An Update on Radio-Immunotherapy

Biological Functions of MicroRNAs

Biomarkers for Development of Cancer Vaccines

Bio-IT World Briefing On: Boosting Productivity In Healthcare

Common Factors Impacting the Utility and Commercialization of Any Cell Therapy

Current Challenges of Real-Time PCR Quantitation.

Creating an Alliance Management Capability

Diagnosis, Prognosis, and Therapy Selection

Drug Development: Last Frontier of Automation

Drug-Induced Torsade de Pointes and Implications for Drug Development

Doubling IT Innovation Spending: Laying the Foundation for IT-Enabled Business Process, Supply Chain, and Service Innovation in the Pharmaceutical Industry

Enterprise Strategy Execution

Exploiting the Untapped Promise of Drug Repositioning

Epigenetic Gene Regulation: Early Environmental Exposures (Future Medicine)

Genome-Based Biomarkers for Adverse Drug Effects, Patient enrichment and Prediction of Drug Response, and Their Incorporation Into Clinical Trial Design

How to Choose the Right Molecular Diagnostics Technology using a Decision Analysis Matrix

How To Make Dendritic Cells Work in Cancer

Implementing an Alliance-Dependent Strategy

Modulation Angiogenesis Pathway Using siRNA Inhibitors

Multi-color fluorescent proteins for in vivo imaging

Notes of a Protein Crystallographer: Quo Vadis Structural Biology?

Nucleic Acid Quantification and Disease Outcome Prediction in Colorectal Cancer

Magnetic Micro- and Nano-Particle-Based Targeting for Drug and Gene Delivery

Negotiating as a Cross-functional Project Manager: Lessons from Alliance Management

'Omics'-Based Imaging in Cancer Detection and Therapy

Portfolio Management a Tool for Our Time

Project Management in Biopharma: A Necessary Evil or a Source of Competitive Advantage?

Process Map Proposal for The Validation of Genomic Biomarkers

Personalized Healthcare 2010

Principled, Effective Data Mining for Systems Biology

Portfolio Management: a Tool for Our Time

Principled, Effective Data Mining for Systems Biology

Progressive Project Management Focus ®: A Strategy to Accelerate Drug Product Development

Protein Tomography ™ Pictures that prove your theory

Read more about the Molecular Diagnostics Conference in the February 1, 2007 is of Genetic Engineering News.

SCREEN DREAMS: The Promise of Parallel Screening

Senior Management_Disabler or Enabler of Alliance Success

SNPs as powerful tools for Association

Strategic Opportunities In Molecular Diagnostics Sector Review By TSG Partners

Strategic Opportunities in Point-of-Care Diagnostics Sector Review By TSG Partners

Strategic Opportunities In Genomics Tools Sector Review By TSG Partners Strategic Advisors

Successful Pharmacogenomics Business Models

Template Synthesized Nanotubes for Biomedical Delivery Applications.

The Consortium for Metabonomic Toxicology (COMET): Aims, Activities and Achievements

The Challenge of Improving the Drug Discovery Process - An Early ADME Perspective

The Era of ErbB-Receptor-Targeted Therapies: Advances Toward Personalized Medicine

The Future of PCR with the Expiration of PCR Patents

The Need for a New Molecular Diagnostic Business Model to Fit the Needs of Personalized Medicine

The Next Generation of Immunoassay Technologies

TaqMan ® Gene Expression Assays for Validating Hits From Fluorescent Microarrays

Therapeutic Approaches for Prion Disorders

Transcriptional Profiling of Multiple Sclerosis: Towards Improved Diagnosis and Treatment

Trends in Library Design and Synthesis

You've Closed the Deal, Now What? What it Takes to Ensure a Successful Alliance or Partnership

By Series:
By Region:

Top Searches